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The present work focuses on a specific challenge of great clinical importance: targeted therapy for 
osteoarthritis (OA). The identification of molecules expressed exclusively, or at elevated levels, by 
cartilage cells (chondrocytes) in OA conditions might provide a strategy for targeted OA therapy by 
enhancing drug specificity. Towards this goal, we report the identification of peptide ligands, that 
bind selectively and with affinity to OA chondrocytes, using phage display, a technology in which a 
library of phage particles expressing a wide diversity of peptides is screened to identify those that 
bind the desired target. A random 12-mer peptide library, displayed on the surface of a filamentous 
phage (M13), was screened by biopanning against the surface of OA chondrocytes to identify 
peptide ligands specific for these cells. Healthy and OA chondrocytes for the panning experiments 
were isolated from cartilage samples obtained in local hospitals under pre-established agreement 
and from patients after informed consent. Isolation and expansion of chondrocytes was performed 
according to published procedures and their phenotype was characterized by FACS (CD44, CD26, 
CD10 and CD95), RT-PCR (aggrecan, collagen I, II and X and Sox9), immunohistochemistry 
(collagen I, II and X), SDS-PAGE and western blot analyses. The identified peptide sequences are 
being integrated into nanocarrier systems formed by self-assembling approaches and the potential 
of these targeted delivery systems is currently being tested in vitro. This approach, if successful, will 
yield important insights into the regenerative mechanisms of cartilage and could be applied for 
developing more efficient and less invasive therapies for treating OA.  

